Coeur Mining Down 27% in a Month, but Shorts Aren't Piling In

CDE has lost 27% over the past month, closing at $13.10 on October 30, yet the short interest picture tells a different story from the price action. Short interest at 8.5% of free float is meaningful but has barely moved, up just 1% on the week and essentially flat over the month. Borrow costs remain low at 0.44%, and availability is at 1,284%, meaning roughly 13 shares are available to lend for every one currently borrowed. There is no evidence of a crowded short building into the November 4 earnings date.

Options traders are not positioned defensively either. The put/call ratio has drifted down to 0.34, about 1.4 standard deviations below its 20-day average of 0.36. That reading is close to the 52-week low of 0.22 and well below the high of 0.57 reached in late September. The message from the options market is that call activity is running hotter than usual, unusual given the severity of the recent selloff.

The 27% monthly drop raises a valuation question the Street appears to be watching. Consensus is buy, with five buy ratings and three outperforms against one hold. Price targets cluster in the mid-to-upper $20s, implying more than 100% upside from current levels, a gap wide enough to be worth examining. Scotiabank trimmed its target to $26.50 after the August print, and Canaccord upgraded to buy in late April. CIBC initiated at Outperformer with a $40 target in March. The bull case rests on a dramatic balance sheet repair: net leverage fell from 2.9x a year ago to 0.4x as recently as Q2, alongside gold production of 108.5 koz and silver of 4.7 Moz that beat forecasts. Bears point to valuation sustainability, noting that a 50% compression in target multiples would erase most of the upside case. The EV/EBITDA multiple has contracted about 10% over the past month to 3.8x, and the P/E has fallen to 7.7x, so some of that compression is already visible in the numbers.

The most interesting ownership development is in the activist register. Vanguard filed a 13G/A in March showing its stake had fallen to zero from 9.1%, exiting what had been a substantial position. BlackRock, by contrast, reported 11.7% in July and the institutional data shows the firm added roughly 26 million shares in the most recent quarter to reach 12.4%. State Street and Vanguard Capital added materially in the same period. The broad institutional buying sits in sharp contrast to insider activity: the CFO and a director both sold in August at prices around $20 to $21, well above where the stock trades today, and net insider sales over the past 90 days total roughly $1 million.

One data point from the Mine Safety and Health Administration is worth noting ahead of the print. MSHA records show employee hours worked in Q2 2026 were the smallest for any second quarter in five years at 468,666 hours, while average employee headcount has risen for four consecutive quarters, reaching 1,187 in April. Neither dataset has been measured to lead the company's reported financials, so they are context rather than signal, but the divergence between rising headcount and falling hours points to a production environment worth probing on the call.

CDE fell 3.5% the day after its August print and then recovered 16% over the following week. Closest peer HL dropped 6.4% on the same October 30 session that CDE fell 6.7%, while NEM fell a more modest 4.6%. CDE's 2.6% weekly decline was actually narrower than the peer median of 4.0%, suggesting the underperformance is more a month-long story than a week-long one.

The November 4 print will test whether the operational improvements and balance sheet repair that drove the Q2 beat have been sustained through Q3, and whether the company can provide a production trajectory that closes the gap between the current $13 stock price and a Street consensus sitting more than 100% above it.